查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1676104

全球兽医肿瘤市场研究报告 - 产业分析、规模、份额、成长、趋势和预测 2025 年至 2033 年

Global Veterinary Oncology Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 140 Pages | 商品交期: 最快1-2个工作天内

价格

全球兽医肿瘤市场规模预计将从 2024 年的 7.5 亿美元增长到 2033 年的 21.3 亿美元，在 2026 年至 2033 年的预测期内呈现 12.22% 的强劲年复合成长率(CAGR)。

随着人们对宠物健康的认识和动物癌症的盛行率不断提高，兽医肿瘤市场正在经历强劲增长。随着宠物主人越来越多地为他们心爱的伙伴寻求先进的治疗选择，对兽医肿瘤服务和产品的需求正在扩大。人们对宠物健康的日益关注，加上兽医学的进步，推动了动物癌症治疗创新疗法和诊断工具的发展。由于兽医实践优先考虑对肿瘤患者的专门护理，兽医肿瘤学市场预计将蓬勃发展。

技术进步在塑造兽医肿瘤市场的未来方面发挥着至关重要的作用。 MRI 和 CT 扫描等诊断影像领域的创新增强了检测和监测宠物肿瘤的能力，从而可以更早、更准确地进行诊断。此外，标靶治疗和免疫疗法的发展正在彻底改变兽医学中的癌症治疗，为宠物主人提供更有效、更少侵入性的选择。随着製造商和兽医专业人员继续在研发方面进行合作，兽医肿瘤市场可能会更多地采用先进的治疗方式和技术。

此外，对个人化医疗和宠物护理整体方法的日益重视正在影响兽医肿瘤学市场。随着宠物主人对宠物健康状况的了解越来越多，对于考虑到个别患者需求和偏好的客製化治疗计划的需求也越来越大。这一趋势推动了综合肿瘤服务的发展，将传统治疗与营养和疼痛管理等补充疗法相结合。随着市场的不断发展，技术、个人化护理和整体方法的整合将成为兽医肿瘤学领域成功的关键驱动力。

我们的报告经过精心製作，为客户提供有关各个行业和市场的全面且可操作的见解。每份报告都包含几个关键部分，以确保彻底了解市场格局：

市场概览：市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本节探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准将市场细分为不同的细分市场。该分析强调了每个部分的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本节深入介绍领先公司的竞争动态和关键策略。

市场预测：根据历史资料和当前市场状况，预测特定时期内的市场规模和成长趋势。这包括定量分析和图形表示来说明未来的市场轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前和新兴的市场趋势、技术创新和潜在投资领域。本节提供未来市场发展和成长前景的见解。

目录

第 1 章：前言

  • 报告描述
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究流程
    • 市场研究方法

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：兽医肿瘤学产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 依动物类型分析市场吸引力
    • 按治疗类型进行的市场吸引力分析
    • 按管理模式进行的市场吸引力分析
    • 市场吸引力分析：按应用
    • 按配销通路进行市场吸引力分析
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料製造商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球兽医肿瘤市场分析：按动物类型

  • 依动物类型概述
  • 按动物类型进行的历史和预测数据分析
  • 伴侣动物（马、犬、猫）
  • 牲畜动物

第 6 章：全球兽医肿瘤市场分析：依治疗类型

  • 按治疗类型概述
  • 按治疗类型进行的历史和预测数据分析
  • 化疗
  • 合併治疗
  • 免疫疗法
  • 标靶治疗

第 7 章：全球兽医肿瘤市场分析：依管理模式

  • 依管理模式概述
  • 按管理模式进行的历史和预测资料分析
  • 口服
  • 静脉

第 8 章：全球兽医肿瘤市场分析：按应用

  • 概述：按应用
  • 历史和预测数据分析：按应用
  • 犬淋巴瘤
  • 骨肉瘤 (OSA)
  • 肥大细胞癌
  • 黑色素瘤
  • 其他的

第 9 章：全球兽医肿瘤市场分析：按分销管道

  • 按配销通路概览
  • 按配销通路进行的历史和预测资料分析
  • 医院药房
  • 政府机构
  • 零售药局

第 10 章：全球兽医肿瘤市场分析：按地区划分

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概述、历史和预测数据销售分析
    • 北美各细分市场销售分析
    • 北美各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测数据销售分析
    • 欧洲各细分市场销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测数据销售分析
    • 亚太地区分部销售分析
    • 亚太地区国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测数据销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测数据销售分析
    • 中东和非洲分部销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第 11 章：兽医肿瘤公司的竞争格局

  • 兽医肿瘤学市场竞争
  • 伙伴关係/合作/协议
  • 合併与收购
  • 新产品发布
  • 其他进展

第 12 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Zoetis Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Elanco
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Boehringer Ingelheim International GmbH
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Merck Animal Health
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Varian Medical Systems
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Accuray Incorporated
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • PetCure Oncology
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • AB Science
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Karyopharm Therapeutics Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Regeneus Ltd
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Morphogenesis Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • VetDC
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Zenoaq
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Rhizen Pharmaceutical SA
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • AdvaVet Inc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，对于私人公司，可能不予涵盖

Product Code: VMR11218350

Global Veterinary Oncology Market size is anticipated to grow from USD 0.75 Billion in 2024 to USD 2.13 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 12.22% during the forecast period of 2026 to 2033.

The Veterinary Oncology Market is experiencing robust growth as the awareness of pet health and the prevalence of cancer in animals continue to rise. As pet owners increasingly seek advanced treatment options for their beloved companions, the demand for veterinary oncology services and products is expanding. The growing focus on pet wellness, coupled with advancements in veterinary medicine, is driving the development of innovative therapies and diagnostic tools for cancer treatment in animals. As veterinary practices prioritize specialized care for oncology patients, the market for veterinary oncology is expected to flourish.

Technological advancements are playing a crucial role in shaping the future of the veterinary oncology market. Innovations in diagnostic imaging, such as MRI and CT scans, are enhancing the ability to detect and monitor tumors in pets, leading to earlier and more accurate diagnoses. Additionally, the development of targeted therapies and immunotherapies is revolutionizing cancer treatment in veterinary medicine, offering more effective and less invasive options for pet owners. As manufacturers and veterinary professionals continue to collaborate on research and development, the veterinary oncology market is likely to see increased adoption of advanced treatment modalities and technologies.

Moreover, the growing emphasis on personalized medicine and holistic approaches to pet care is influencing the veterinary oncology market. As pet owners become more informed about their pets' health, there is a rising demand for tailored treatment plans that consider individual patient needs and preferences. This trend is driving the development of integrative oncology services that combine conventional treatments with complementary therapies, such as nutrition and pain management. As the market continues to evolve, the integration of technology, personalized care, and holistic approaches will be key drivers of success in the veterinary oncology sector.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Animal Type

  • Companion Animal (Equine, Canine, and Feline)
  • Livestock Animal

By Therapy Type

  • Chemotherapy
  • Combination Therapy
  • Immunotherapy
  • Targeted Therapy

By Mode of Administration

  • Oral
  • Intravenous

By Application

  • Canine Lymphoma
  • Osteosarcoma (OSA)
  • Mast Cell Cancer
  • Melanoma
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Government Agencies
  • Retail Pharmacies
  • COMPANIES PROFILED
  • Zoetis Inc.
  • Elanco
  • Boehringer Ingelheim International GmbH
  • Merck Animal Health
  • Varian Medical Systems
  • Accuray Incorporated
  • PetCure Oncology
  • AB Science
  • Karyopharm Therapeutics Inc.
  • Regeneus Ltd
  • Morphogenesis Inc.
  • VetDC
  • Zenoaq
  • Rhizen Pharmaceutical SA
  • AdvaVet Inc.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. VETERINARY ONCOLOGY INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Animal Type
    • 3.7.2 Market Attractiveness Analysis By Therapy Type
    • 3.7.3 Market Attractiveness Analysis By Mode of Administration
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By Distribution Channel
    • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL VETERINARY ONCOLOGY MARKET ANALYSIS BY ANIMAL TYPE

  • 5.1. Overview By Animal Type
  • 5.2. Historical and Forecast Data Analysis By Animal Type
  • 5.3. Companion Animal (Equine, Canine, and Feline) Historic and Forecast Sales By Regions
  • 5.4. Livestock Animal Historic and Forecast Sales By Regions

6. GLOBAL VETERINARY ONCOLOGY MARKET ANALYSIS BY THERAPY TYPE

  • 6.1. Overview By Therapy Type
  • 6.2. Historical and Forecast Data Analysis By Therapy Type
  • 6.3. Chemotherapy Historic and Forecast Sales By Regions
  • 6.4. Combination Therapy Historic and Forecast Sales By Regions
  • 6.5. Immunotherapy Historic and Forecast Sales By Regions
  • 6.6. Targeted Therapy Historic and Forecast Sales By Regions

7. GLOBAL VETERINARY ONCOLOGY MARKET ANALYSIS BY MODE OF ADMINISTRATION

  • 7.1. Overview By Mode of Administration
  • 7.2. Historical and Forecast Data Analysis By Mode of Administration
  • 7.3. Oral Historic and Forecast Sales By Regions
  • 7.4. Intravenous Historic and Forecast Sales By Regions

8. GLOBAL VETERINARY ONCOLOGY MARKET ANALYSIS BY APPLICATION

  • 8.1. Overview By Application
  • 8.2. Historical and Forecast Data Analysis By Application
  • 8.3. Canine Lymphoma Historic and Forecast Sales By Regions
  • 8.4. Osteosarcoma (OSA) Historic and Forecast Sales By Regions
  • 8.5. Mast Cell Cancer Historic and Forecast Sales By Regions
  • 8.6. Melanoma Historic and Forecast Sales By Regions
  • 8.7. Others Historic and Forecast Sales By Regions

9. GLOBAL VETERINARY ONCOLOGY MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 9.1. Overview By Distribution Channel
  • 9.2. Historical and Forecast Data Analysis By Distribution Channel
  • 9.3. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 9.4. Government Agencies Historic and Forecast Sales By Regions
  • 9.5. Retail Pharmacies Historic and Forecast Sales By Regions

10. GLOBAL VETERINARY ONCOLOGY MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2 North America By Segment Sales Analysis
    • 10.3.3 North America By Country Sales Analysis
    • 10.3.4 United States Sales Analysis
    • 10.3.5 Canada Sales Analysis
    • 10.3.6 Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2 Europe By Segment Sales Analysis
    • 10.4.3 Europe By Country Sales Analysis
    • 10.4.4 United Kingdom Sales Analysis
    • 10.4.5 France Sales Analysis
    • 10.4.6 Germany Sales Analysis
    • 10.4.7 Italy Sales Analysis
    • 10.4.8 Russia Sales Analysis
    • 10.4.9 Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2 Asia Pacific By Segment Sales Analysis
    • 10.5.3 Asia Pacific By Country Sales Analysis
    • 10.5.4 China Sales Analysis
    • 10.5.5 India Sales Analysis
    • 10.5.6 Japan Sales Analysis
    • 10.5.7 South Korea Sales Analysis
    • 10.5.8 Australia Sales Analysis
    • 10.5.9 South East Asia Sales Analysis
    • 10.5.10 Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2 Latin America By Segment Sales Analysis
    • 10.6.3 Latin America By Country Sales Analysis
    • 10.6.4 Brazil Sales Analysis
    • 10.6.5 Argentina Sales Analysis
    • 10.6.6 Peru Sales Analysis
    • 10.6.7 Chile Sales Analysis
    • 10.6.8 Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2 Middle East & Africa By Segment Sales Analysis
    • 10.7.3 Middle East & Africa By Country Sales Analysis
    • 10.7.4 Saudi Arabia Sales Analysis
    • 10.7.5 UAE Sales Analysis
    • 10.7.6 Israel Sales Analysis
    • 10.7.7 South Africa Sales Analysis
    • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE VETERINARY ONCOLOGY COMPANIES

  • 11.1. Veterinary Oncology Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12. COMPANY PROFILES OF VETERINARY ONCOLOGY INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Zoetis Inc.
    • 12.3.1 Company Overview
    • 12.3.2 Company Revenue
    • 12.3.3 Products
    • 12.3.4 Recent Developments
  • 12.4. Elanco
    • 12.4.1 Company Overview
    • 12.4.2 Company Revenue
    • 12.4.3 Products
    • 12.4.4 Recent Developments
  • 12.5. Boehringer Ingelheim International GmbH
    • 12.5.1 Company Overview
    • 12.5.2 Company Revenue
    • 12.5.3 Products
    • 12.5.4 Recent Developments
  • 12.6. Merck Animal Health
    • 12.6.1 Company Overview
    • 12.6.2 Company Revenue
    • 12.6.3 Products
    • 12.6.4 Recent Developments
  • 12.7. Varian Medical Systems
    • 12.7.1 Company Overview
    • 12.7.2 Company Revenue
    • 12.7.3 Products
    • 12.7.4 Recent Developments
  • 12.8. Accuray Incorporated
    • 12.8.1 Company Overview
    • 12.8.2 Company Revenue
    • 12.8.3 Products
    • 12.8.4 Recent Developments
  • 12.9. PetCure Oncology
    • 12.9.1 Company Overview
    • 12.9.2 Company Revenue
    • 12.9.3 Products
    • 12.9.4 Recent Developments
  • 12.10. AB Science
    • 12.10.1 Company Overview
    • 12.10.2 Company Revenue
    • 12.10.3 Products
    • 12.10.4 Recent Developments
  • 12.11. Karyopharm Therapeutics Inc.
    • 12.11.1 Company Overview
    • 12.11.2 Company Revenue
    • 12.11.3 Products
    • 12.11.4 Recent Developments
  • 12.12. Regeneus Ltd
    • 12.12.1 Company Overview
    • 12.12.2 Company Revenue
    • 12.12.3 Products
    • 12.12.4 Recent Developments
  • 12.13. Morphogenesis Inc.
    • 12.13.1 Company Overview
    • 12.13.2 Company Revenue
    • 12.13.3 Products
    • 12.13.4 Recent Developments
  • 12.14. VetDC
    • 12.14.1 Company Overview
    • 12.14.2 Company Revenue
    • 12.14.3 Products
    • 12.14.4 Recent Developments
  • 12.15. Zenoaq
    • 12.15.1 Company Overview
    • 12.15.2 Company Revenue
    • 12.15.3 Products
    • 12.15.4 Recent Developments
  • 12.16. Rhizen Pharmaceutical SA
    • 12.16.1 Company Overview
    • 12.16.2 Company Revenue
    • 12.16.3 Products
    • 12.16.4 Recent Developments
  • 12.17. AdvaVet Inc
    • 12.17.1 Company Overview
    • 12.17.2 Company Revenue
    • 12.17.3 Products
    • 12.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Animal Type (USD MN)
  • Companion Animal (Equine, Canine, and Feline) Market Sales By Geography (USD MN)
  • Livestock Animal Market Sales By Geography (USD MN)
  • Analysis By Therapy Type (USD MN)
  • Chemotherapy Market Sales By Geography (USD MN)
  • Combination Therapy Market Sales By Geography (USD MN)
  • Immunotherapy Market Sales By Geography (USD MN)
  • Targeted Therapy Market Sales By Geography (USD MN)
  • Analysis By Mode of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Intravenous Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Canine Lymphoma Market Sales By Geography (USD MN)
  • Osteosarcoma (OSA) Market Sales By Geography (USD MN)
  • Mast Cell Cancer Market Sales By Geography (USD MN)
  • Melanoma Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Government Agencies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Global Veterinary Oncology Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Veterinary Oncology Report
  • Market Research Process
  • Market Research Methodology
  • Global Veterinary Oncology Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Animal Type
  • Market Attractiveness Analysis By Therapy Type
  • Market Attractiveness Analysis By Mode of Administration
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Animal Type (USD MN)
  • Companion Animal (Equine, Canine, and Feline) Market Sales By Geography (USD MN)
  • Livestock Animal Market Sales By Geography (USD MN)
  • Global Market Analysis By Therapy Type (USD MN)
  • Chemotherapy Market Sales By Geography (USD MN)
  • Combination Therapy Market Sales By Geography (USD MN)
  • Immunotherapy Market Sales By Geography (USD MN)
  • Targeted Therapy Market Sales By Geography (USD MN)
  • Global Market Analysis By Mode of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Intravenous Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Canine Lymphoma Market Sales By Geography (USD MN)
  • Osteosarcoma (OSA) Market Sales By Geography (USD MN)
  • Mast Cell Cancer Market Sales By Geography (USD MN)
  • Melanoma Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Government Agencies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.